(Sharecast News) - London stocks nudged just a touch higher in early trade on Thursday as investors eyed an expected rate cut by the European Central Bank. At 0835 BST, the FTSE 100 was up 0.1% at ...

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and ...

The FTSE 100 index closed up 12.76 points, 0.2%, at 8,787.02. The FTSE 250 ended down 11.19 points, 0.1%, at 21,017.78, and the AIM All-Share closed up 5.38 points, 0.7%, at 753.51.

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Chinmay Sharma, Executive Vice President - ...

London: GSK plc has announced the New Drug Application (NDA) for linerixibat, an investigational targeted inhibitor of the ...

Stephen Hemsley returned to the top job last month after the healthcare giant reported its first earnings miss since 2008.

Andrew Witty, who largely led the U.S. healthcare giant from the U.K., made big bets on Medicare enrollees that backfired.

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat.

There’s already overlap in the pharmaceutical industry between the U.K. and Pennsylvania, but details in Trump’s trade deal ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

The UK life sciences property sector has been on a rollercoaster ride in the years since the Covid-19 outbreak.